Overcoming barriers to adult immunization in Europe: A decalogue for policy action by the Adult Immunization Board
Authors:
- Sara BoccaliniSBSara Boccalini
- Marco Del RiccioMarco Del Riccio
- Birgit WeinbergerBWBirgit Weinberger
- Domenico MartinelliDMDomenico Martinelli
- Angela BechiniABAngela Bechini
- Greet HendrickxGHGreet Hendrickx
- Paolo BonanniPBPaolo Bonanni
- Pierre Van DammePDPierre Van Damme
- Per LjungmanPLPer Ljungman
- Sotirios TsiodrasSotirios Tsiodras
- Odile LaunayOLOdile Launay
- Giovanni GabuttiGGGiovanni Gabutti
Open Access
- 18 February 2026
- journal article
- Published by Elsevier in Health Policy and Technology
- Vol. 15 (4)
Abstract
No abstract availableFunding Information
- Universiteit Antwerpen
- Università degli Studi di Firenze
This publication has 9 references indexed in Scilit:
- Strategies for introducing and implementing vaccines for adults into national immunization programs in Europe: Good practices and key insights of the adult immunization board meetingHuman Vaccines & Immunotherapeutics, 2025
- Overview of adult immunization in Italy: Successes, lessons learned and the way forwardHuman Vaccines & Immunotherapeutics, 2024
- The Adult Immunization Board (AIB): A new platform to provide multidisciplinary guidelines for the implementation and optimization of adult immunization in EuropeVaccine, 2023
- Assessing the health burden of vaccine-preventable infections in European adults: challenges and opportunities translated into actionEurosurveillance, 2023
- Role of the National Immunisation Technical Advisory Groups in 13 European countries in the decision-making process on vaccine recommendationsEurosurveillance, 2023
- Exploring missed opportunities for influenza vaccination and influenza vaccine co-administration patterns among Italian older adults: a retrospective cohort studyEuropean Journal of Public Health, 2023
- Defining and measuring vaccine hesitancyNature Human Behaviour, 2022
- Global epidemiology of non-influenza RNA respiratory viruses: data gaps and a growing need for surveillanceThe Lancet Infectious Diseases, 2017
- The complexity and cost of vaccine manufacturing – An overviewVaccine, 2017